• Diabetes is the 7th leading cause of death in the U.S.
• In 2015, 30.3 million Americans—9.4% of the population—had diabetes.
• Among those age 65 and older, that rises to 25.2%, or 12.0 million seniors (diagnosed and undiagnosed).
• 1.5 million Americans are diagnosed with diabetes every year; 4,110 a day.
• In 2015, 84.1 million Americans age 18 and older had prediabetes.
• Every day, an average of 295 Americans will undergo an amputation due to diabetes.
• Every day, another 137 Americans will enter end-stage kidney disease treatment due to diabetes.
• The cost of diagnosed diabetes in the U.S. in 2017: $327 billion, which is $237 billion for direct medical costs and $90 billion in reduced productivity. This is up from $245 billion in 2012, when the cost was last examined; a 26% increase.
• People with diagnosed diabetes incur average medical expenditures of $16,752 per year, which is approximately 2.3 times higher than what they would have been in the absence of diabetes.
• Care for people with diabetes accounts for 1 in 4 health care dollars in the U.S.
(Statistics: American Diabetes Association)
The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), is the primary institute at the National Institutes of Health (a part of the U.S. Department of Health and Human Services and the largest biomedical research agency in the world) supporting diabetes research. According to the American Diabetes Association®, “Funding for NIDDK is essential to preventing diabetes, improving the lives of people living with the disease, and—ultimately— curing diabetes. Funding for NIDDK has not kept pace with biomedical inflation, let alone the country’s growing diabetes epidemic.
As a result, many promising diabetes research projects go unfunded.” The primary treatment for controlling blood sugar levels in diabetics is insulin, which was developed in 1921. Unfortunately, it hasn’t had many changes other than being refined to adjust how fast it works.
Type 1 diabetes (T1D), sometimes known as juvenile diabetes, has no known cure, and no prevention measures since the cause is unknown. While insulin therapy keeps people with T1D alive, it’s not a cure, and cannot prevent the possibility of severe side effects. It requires constant management including measuring blood-sugar levels ideally six times per day. About 1.25 million Americans have T1D, including about 200,000 under the age of 20. By 2050, this is expected to rise to 5 million in total and nearly 600,000 youth.
The scope of diabetes’ impact is already huge and continues to expand. Our best hope at finding successful prevention methodologies, treatments, and, eventually, a cure, is to continue research and trials. Meridien Research is conducting numerous diabetes clinical research studies at our six Central Florida clinics and needs volunteers. For more information or to see if you or someone you know may qualify to participate, please contact us today at 1-888-777-8839 or visit NewStudyInfo.com.